NextCure, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NextCure, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q4 2024.
  • NextCure, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.52M, a 23.4% decline year-over-year.
  • NextCure, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $6.34M, a 22.6% decline year-over-year.
  • NextCure, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6.34M, a 22.6% decline from 2023.
  • NextCure, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.19M, a 13.9% decline from 2022.
  • NextCure, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.51M, a 7.58% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $6.34M $1.52M -$465K -23.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 $6.8M $1.53M -$472K -23.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.27M $1.59M -$531K -25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $7.8M $1.69M -$385K -18.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $8.19M $1.98M -$342K -14.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 $8.53M $2M -$311K -13.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $8.84M $2.13M -$117K -5.22% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $8.96M $2.08M -$550K -20.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $9.51M $2.33M -$184K -7.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $9.69M $2.31M -$171K -6.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $9.86M $2.24M -$545K -19.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $10.4M $2.63M +$120K +4.79% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $10.3M $2.51M +$166K +7.08% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $10.1M $2.48M +$111K +4.68% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $10M $2.79M +$600K +27.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $9.41M $2.51M +$1.5M +149% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $7.91M $2.34M +$1.78M +313% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $6.13M $2.37M +$1.85M +353% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $4.29M $2.19M +$1.78M +431% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.51M $1.01M +$625K +163% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.89M $567K +$442K +354% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $1.44M $524K +$434K +482% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.01M $412K +$388K +1617% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $622K $383K +$359K +1496% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $263K $125K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $90K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $24K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $24K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.